Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 8, 2008 - Issue 6
Submit an article Journal homepage
113
Views
13
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Overview of the findings from the European SOHO study

David Suarez Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr. Antoni Pujades, 42 08830 – Sant Boi de Llobregat (Barcelona), Spain. [email protected]
&
Josep Maria Haro Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), ISCIII, Dr. Antoni Pujades, 42, 08830 – Sant Boi de Llobregat (Barcelona), Spain. [email protected]
Pages 873-880 | Published online: 09 Jan 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michihiro Takahashi, Naohiro Nakahara, Shinji Fujikoshi & Masaomi Iyo. (2015) Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study. Pragmatic and Observational Research 6, pages 39-46.
Read now

Articles from other publishers (12)

Elmars Rancans, Zsófia Borbála Dombi, Péter Mátrai, Ágota Barabássy, Barbara Sebe, Iveta Skrivele & György Németh. (2021) The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study. International Clinical Psychopharmacology 36:3, pages 154-161.
Crossref
Thomas RE Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia MA Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck & Alison R Yung. (2019) Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 34:1, pages 3-78.
Crossref
Mamta SapraDonna LawsonAli Iranmanesh. (2018) Fat Distribution in Schizophrenia Patients. Journal of Clinical Psychopharmacology 38:1, pages 68-71.
Crossref
Mette Vinther Hansen, Peter Hjorth, Christina Blanner Kristiansen, Kirsten Vandborg, Lea Nørgaard Gustafsson & Povl Munk-Jørgensen. (2016) Reducing cardiovascular risk factors in non-selected outpatients with schizophrenia. International Journal of Social Psychiatry 62:4, pages 369-376.
Crossref
Mette Vinther Hansen, Peter Hjorth, Christina Blanner Kristiansen, Kirsten Vandborg, Lea Nørgaard Gustafsson & Povl Munk-Jørgensen. (2016) Reducing cardiovascular risk factors in non-selected outpatients with schizophrenia. International Journal of Social Psychiatry 62:4, pages 400-407.
Crossref
Yong K. H. Michael, Norman Sartorius & Kang Sim. 2013. Polypharmacy in Psychiatry Practice, Volume II. Polypharmacy in Psychiatry Practice, Volume II 61 80 .
Susanne Kraemer, Florence Chartier, Béatrice Augendre‐Ferrante, Vassiliki Psarra, Yulia D'yachkova, Anke Beselin & Fréderic Rouillon. (2012) Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1‐year European observational study. Human Psychopharmacology: Clinical and Experimental 27:3, pages 284-294.
Crossref
Thomas RE Barnes. (2011) Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 25:5, pages 567-620.
Crossref
Eva-Marina Beck, Marialuisa Cavelti, Markus Wirtz, Joe Kossowsky & Roland Vauth. (2011) How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach. Psychiatry Research 187:1-2, pages 55-61.
Crossref
Diego Novick, Josep Maria Haro, David Suarez, Victor Perez, Ralf W. Dittmann & Peter M. Haddad. (2010) Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research 176:2-3, pages 109-113.
Crossref
I. Gasquet, F. Chartier, S. Tcherny-Lessenot & J.-P. Lépine. (2009) Étude Schizophrenia Outpatient Health Outcomes (SOHO) France : étude observationnelle à 36 mois d’une cohorte de patients schizophrènes ambulatoires traités par antipsychotiques. Revue d'Épidémiologie et de Santé Publique 57:1, pages 25-32.
Crossref
A.J. Scheen, R. van Winkel & M.A. De Hert. (2008) Traitements neuroleptiques et troubles métaboliques. Médecine des Maladies Métaboliques 2:6, pages 593-599.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.